Exhibit 99.2

 

MRI INTERVENTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

   March 31,
2019		  Pro Forma Adjustments 

Pro Forma

March 31, 2019

ASSETS               
Current Assets:               
Cash and cash equivalents  $2,491,670   $7,522,011(1)  $10,013,681 
Accounts receivable   1,266,797         1,266,797 
Inventory, net   2,024,935         2,024,935 
Operating lease rights of use, current portion   98,668         98,668 
Prepaid expenses and other current assets   199,576         199,576 
Total current assets   6,081,646    7,522,011    13,603,657 
                
Property and equipment, net   498,783         498,783 
Software license inventory   679,400         679,400 
Operating lease rights of use   355,176         355,176 
Other assets   10,639         10,639 
Total assets  $7,625,644   $7,522,011   $15,147,655 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY               
Current liabilities:               
Accounts payable  $502,986   $100,000(2)  $602,986 
Accrued compensation   667,768         667,768 
Operating lease liabilities, current portion   104,127         104,127 
Other accrued liabilities   319,654         319,654 
Deferred revenue   679,485         679,485 
Total current liabilities   2,274,020    100,000    2,374,020 
                
Accrued interest   892,125         892,125 
2014 junior secured notes payable, net   1,944,871         1,944,871 
Operating lease liabilities   367,061         367,061 
2010 junior secured notes payable, net   1,704,948         1,704,948 
Total liabilities   7,183,025    100,000    7,283,025 
Commitments and contingencies               
Stockholders’ equity:               
Preferred stock   —             
Common stock   110,672    24,265(1)   134,937 
Additional paid-in capital   108,752,502    7,397,746(1)(2)   116,150,248 
Accumulated deficit   (108,420,555)        (108,420,555)
Total stockholders’ equity   442,619    7,422,011    7,864,630 
Total liabilities and stockholders’ equity  $7,625,644   $7,522,011   $15,147,655 

 

(1) Reflects the receipt of proceeds of $7,522,011 in the Financing Transaction.

(2) Reflects the costs, estimated to be $100,000, to be incurred in connection with the Financing Transaction.